| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.15 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $80.31 $60.23 (25%) | 🛒 Add to cart |
| 30 | $2.34 | $120.46 $70.27 (42%) | 🛒 Add to cart |
| 60 | $1.34 | $240.93 $80.31 (67%) | 🛒 Add to cart |
| 90 | $1.00 | $361.39 $90.35 (75%) | 🛒 Add to cart |
| 120 | $0.84 | $481.86 $100.39 (79%) | 🛒 Add to cart |
| 180 | $0.75 | $722.78 $135.52 (81%) | 🛒 Add to cart |
| 270 | $0.67 | $1084.18 $180.70 (83%) | 🛒 Add to cart |
| 360 | $0.59
Best per pill | $1445.57 $210.81 (85%) | 🛒 Add to cart |
Similar products
More info:
zyban
Zyban, known generically as bupropion hydrochloride, is a prescription medication primarily indicated as an aid to smoking cessation treatment. It’s classified as an atypical antidepressant and norepinephrine-dopamine reuptake inhibitor (NDRI), which sets it apart from traditional SSRIs. What’s fascinating is how we stumbled upon its anti-smoking properties - initially developed as an antidepressant, clinicians noticed patients spontaneously reporting reduced cigarette cravings. That accidental discovery revolutionized smoking cessation protocols and gave us our first non-nicotine pharmaceutical option for tobacco dependence.
Bupropion: Effective Depression and Smoking Cessation Treatment - Evidence-Based Review
Bupropion is an atypical antidepressant and smoking cessation aid belonging to the norepinephrine-dopamine reuptake inhibitor (NDRI) class. Unlike traditional SSRIs, it uniquely increases dopamine and norepinephrine activity without significant serotonergic effects, which explains its distinct therapeutic profile and side effect pattern. Initially approved in 1985 and available under brand names like Wellbutrin and Zyban, it has become a cornerstone in managing major depressive disorder, seasonal affective disorder, and nicotine dependence, particularly valued for its minimal sexual side effects and potential for weight neutrality or loss.
wellbutrin
Wellbutrin, known generically as bupropion, is an atypical antidepressant and smoking cessation aid that’s been in clinical use for decades. It’s chemically distinct from SSRIs and other common antidepressants, functioning primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI). What’s fascinating about this medication is how it diverges from the typical serotonin-focused approach that dominated depression treatment for years. Wellbutrin: Effective Depression and Smoking Cessation Treatment - Evidence-Based Review 1. Introduction: What is Wellbutrin?
Wellbutrin SR: Effective Depression Treatment with Minimal Sexual Side Effects - Evidence-Based Review
Wellbutrin SR is an extended-release formulation of bupropion hydrochloride, a unique antidepressant that’s been part of our psychiatric toolkit since the 1980s. Unlike many antidepressants that primarily target serotonin, this one works mainly on norepinephrine and dopamine pathways. I remember first encountering it during my residency when an attending physician described it as “the antidepressant that doesn’t cause weight gain or sexual dysfunction” - which immediately caught my attention given how common those side effects were with SSRIs.
abana
Product Description Abana represents one of those formulations that initially puzzled me when I first encountered it in practice - a comprehensive herbal supplement with roots in Ayurvedic medicine, primarily indicated for cardiovascular support. What struck me during my early years at the Cleveland Clinic was how this multi-herb preparation kept appearing in patients’ medication lists, particularly among those with familial hyperlipidemia patterns. The formulation contains a sophisticated blend of Terminalia arjuna, Inula racemosa, Commiphora mukul, and several other botanicals that work synergistically - something we rarely see in single-component pharmaceuticals.
abhigra
Product Description: Abhigra represents a novel class of medical-grade nutraceutical devices that combines standardized botanical extracts with a patented sublingual delivery system. Unlike conventional supplements, its mechanism relies on transmucosal absorption bypassing first-pass metabolism, which we’ve observed yields significantly faster onset of action—particularly valuable for acute inflammatory episodes. The development team spent three years battling stability issues with the nanoemulsion matrix before discovering that alternating temperature cycles during production actually enhanced bioactive preservation, contrary to our initial assumptions.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily function as dopamine D2 receptor antagonists, aripiprazole exhibits a unique mechanism as a partial dopamine agonist. This pharmacological profile allows it to stabilize dopamine activity rather than simply blocking it, creating what many clinicians describe as a “dopamine stabilizer” effect. The medication has received FDA approval for multiple psychiatric conditions including schizophrenia, bipolar disorder, major depressive disorder (as adjunct treatment), Tourette’s disorder, and irritability associated with autistic disorder.
Acamprol: Targeted Neurological Support for Hyperexcitability Disorders - Evidence-Based Review
In my early neurology practice, we kept hitting walls with certain patients—the ones with persistent neurological irritability where standard GABAergics either failed or caused unacceptable sedation. That’s when our hospital’s pharmacology team first showed me the molecular structure of what would become Acamprol. It wasn’t another benzodiazepine analog or some exotic plant extract, but a synthetic compound mimicking taurine’s neuromodulatory properties. We initially called it “Calcium Acetylhomotaurinate” until the brand name stuck.
Accufine: Advanced Continuous Glucose Monitoring for Diabetes Management - Evidence-Based Review
Product Description: Accufine represents a significant advancement in non-invasive glucose monitoring technology. It’s a continuous glucose monitoring (CGM) system that uses micro-needle sensor technology combined with advanced algorithms to provide real-time interstitial fluid glucose readings without the traditional fingerstick calibration. The device consists of a discreet wearable sensor that transmits data to both a dedicated reader and compatible smartphone applications, allowing for comprehensive glucose trend analysis and predictive alerts. I remember when we first started developing this technology back in 2018 - our team was divided between pursuing traditional electrochemical sensing versus this novel optical approach.